Preparation of kinase-biased compounds in the search for lead inhibitors of kinase targets
Justine Lai, David L. Walker, Rebekah E. Beevers, Parminder Ruprah, Abid Masood, M. I. Shaw, Helen J. Payne, Robert Judkins, Kerry Jenkins, Jess Taylor, Tony Raynham, John Reader, James M. Cobb, James Nally, Neil P. Grimster, Matthew Stirling, Eva Figueroa, Alison M. Reid, Gilles Raphy, Stephen Thompson, Ruth Adams(Millennium Engineering and Integration (United States)), Yvonne Ferguson, Hannah F. Sore, Jeremy P. Major, Steven Langston(Takeda (United States)), Lloyd Payne, Adam C. Talbot, Val�rie Reader, Nawaz Khan, Mark Jones, Andrew Henry, Hiroki Wada, Richard Boyce, Svenja Burckhardt
Cited by 12
Related Papers
Substrate-Assisted Inhibition of Ubiquitin-like Protein-Activating Enzymes: The NEDD8 E1 Inhibitor MLN4924 Forms a NEDD8-AMP Mimetic In Situ
|Molecular Cell|2010|461
A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment
|Nature Medicine|2018|453
Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor
|Nature Chemical Biology|2017|228